Emitents | Grindeks, AS (5299006DWR32NKWM1O86) |
Veids | Būtiski notikumi |
Valoda | EN |
Statuss | Publicēts |
Versija | |
Datums | 2011-11-24 09:44:19 |
Versijas komentārs | |
Teksts |
JSC “Grindeks” informs that it has received the Statement of
“Grindeks” Chairman of the Board Janis Romanovskis on his
resignation from the position of Chairman of the Board starting
from 24th of November. Janis Romanovskis decided to
leave the company of his own
volition.
Janis Romanovskis worked in “Grindeks” since
2003 and previously fulfilled the duties of the Financial and
Administrative director. In 2007 he was appointed in a position of
Chairman of the Board. Chairman
of the Council of
“Grindeks”
Kirovs
Lipmans:
“I would like to express my gratitude to Janis Romanovskis for his
contribution to “Grindeks” growth and work! Over recent years much
has been done in the company – realisation of large-scale projects,
an increase of “Grindeks” export capacity. I am sure that his
experience and knowledge will help him to gain a great career
success in the future.”
Until further decisions the Board of “Grindeks” will continue to
work in composition of two Board Members –
Vadims Rabsa, Finance and Administrative director and Lipmans
Zeligmans, Director of the Final Dosage Forms
Manufacturing.
About
“Grindeks”
“Grindeks”
is the leading pharmaceutical company in the Baltic States. Its
main fields of action are: research, development, manufacturing and
sale of original products, generics and active pharmaceutical
ingredients. The Group of “Grindeks” consists of four subsidiary
companies in Latvia, Estonia and Russia, as well representative
offices in ten countries.
“Grindeks”
specializes in the heart and cardiovascular, CNS and anti-cancer
medication therapeutic groups. A range of products covers a
successful combination of original products and generics, with the
original products Mildronate® and Ftorafur® and more than 100 forms
of effective and safe generics included therein. Currently
“Grindeks” produces 16 active pharmaceutical
ingredients.
Products
of the company are exported to 50 countries and its export
comprises more than 95% of the total turnover. The main markets
are: Russia and other CIS countries, the Baltic States, Germany and
the Netherlands. In 2010 The Ministry of Economics of Republic of
Latvia and Investment and Development Agency of Latvia awarded
“Grindeks” as the most export potential company of Latvia.
During
the last years the company realized many considerable investment
projects in purpose to increase production capacity and develop
infrastructure and invested 32.7 million lats within five
years.
JSC
“Grindeks” shares are listed in the Official List of “NASDAQ OMX
Riga”. Major shareholders of JSC „Grindeks” are Kirovs Lipmans –
33.29%, Anna Lipmane – 16.69%, “Skandinaviska Enskilda Banken” –
12.42%, “AB.LV Private Equity fund 2010” – 11.38%, “Swedbank” AS
Clients Account – 6.87%.
Further
information on the company –
www.grindeks.lv Further
information: Laila
Kļaviņa Head of
the Communications Department, JSC “Grindeks” Phones:
(+371) 67083370, (+371) 29256012 Fax:
(+371) 67083505 www.grindeks.lv |
Pielikumi |
|